MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
---|---|---|
New | Aleve 24 Hour | |
New | APO-Esomeprazole | |
New | APOHealth Iron Tablets | |
New | APOHealth Iron Tablets with Folic Acid | |
New | APX-Clopidogrel/Aspirin 75/100 | |
New | Bosentan Dr. Reddy's | |
New | Cipla Pain Relief Paracetamol and Codeine 8 | |
New | Desflurane Sandoz | |
New | Dulcosoft | |
New | Enerzair Breezhaler | |
New | Erlotinib Sandoz | |
New | Evenity | |
New | Fulvestrant Sandoz | |
New | Medco Paracetamol 500, Codeine Phosphate 10 and Doxylamine Succinate 5.1 | |
New | Metaraminol Apotex | |
New | Noumed Lamotrigine | |
New | Noxicid Caps Heartburn Relief | |
New | Pethidine Juno | |
New | Pharmacy Action Paracetamol Osteo 665 | |
New | Posaconazole Dr. Reddy's | |
New | QV Dermcare Eczema Daily Cream | |
New | QV Dermcare Eczema Daily Wash | |
New | Span-K (New Formulation) | |
New | Tenofovir Sandoz | |
New | Terimide | |
New | ViruPOS | |
Reinstated | Aleve | |
Reinstated | APOHealth Nausea Relief | |
Revised | Acetadote Concentrated Injection | TGA Date |
Revised | Afinitor | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Aimovig | Adverse Effects (Undesirable Effects) |
Revised | Ajovy | Adverse Effects (Undesirable Effects) |
Revised | Alendronate Sandoz | TGA Date |
Revised | Allosig | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, Overdose, Pharmaceutical Form, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Alunbrig | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Amiloxyn | Special Warnings and Precautions for Use |
Revised | Amipride 400 | Adverse Effects (Undesirable Effects) |
Revised | Anastrozole Sandoz | Adverse Effects (Undesirable Effects), Pharmacological Properties |
Revised | AndroForte 5 | Shelf Life |
Revised | Anoro Ellipta | TGA Date |
Revised | Antroquoril | Sponsor |
Revised | Apidra | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | APO-Adefovir | TGA Date |
Revised | APO-Amisulpride | Adverse Effects (Undesirable Effects), Nature and Contents of Container |
Revised | APO-Amoxycillin Capsules | Special Warnings and Precautions for Use |
Revised | APO-Amoxycillin Powder for Suspension | Special Warnings and Precautions for Use |
Revised | APO-Atomoxetine | TGA Date |
Revised | APO-Atorvastatin | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, New contraindication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | APO-Azathioprine | Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | APO-Eplerenone | TGA Date |
Revised | APOHealth Pantoprazole Heartburn Relief | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | APOHealth Sleep Assist | Special Precautions for Storage |
Revised | APO-Raloxifene | TGA Date |
Revised | APO-Sertraline | Adverse Effects (Undesirable Effects), Pharmaceutical Form |
Revised | Atorvachol | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, New contraindication, Pharmacological Properties, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Aubagio | Adverse Effects (Undesirable Effects) |
Revised | Ausfam | TGA Date |
Revised | Avastin | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Avonex | TGA Date |
Revised | Axit | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Azathioprine GH | Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Azathioprine Sandoz | Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | B. Braun Fentanyl | Boxed Warnings, Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Bactroban | TGA Date |
Revised | Bactroban Nasal Ointment | TGA Date |
Revised | Bavencio | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties |
Revised | Baxter Chlorhexidine Acetate with Cetrimide Antiseptic Solution | TGA Date |
Revised | Benztrop | List of Excipients, Overdose |
Revised | Besponsa | Special Warnings and Precautions for Use |
Revised | Blooms the Chemist Atorvastatin | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Blooms the Chemist Sleep Assist | Special Precautions for Storage |
Revised | Bretaris Genuair | Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | BTC Clopidogrel | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | BTC Lercanidipine | Adverse Effects (Undesirable Effects), Contraindications, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Caduet | Sponsor |
Revised | Caelyx | Adverse Effects (Undesirable Effects) |
Revised | Cardiolite | Sponsor, TGA Date |
Revised | Cefalexin Sandoz 500 mg Capsules and Powder for Suspension | Adverse Effects (Undesirable Effects), Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Ceftazidime Juno | Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Celapram | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Celestone-M | Sponsor |
Revised | CellCept | Adverse Effects (Undesirable Effects) |
Revised | Ceptolate | TGA Date |
Revised | Chemists' Own Sleep Aid | Special Precautions for Storage |
Revised | Clopidogrel APOTEX | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Clopidogrel GH | Qualitative and Quantitative Composition |
Revised | Combivir | Special Precautions for Storage |
Revised | Comfarol Forte | Nature and Contents of Container |
Revised | Comirnaty | Shelf Life, Special Precautions for Storage |
Revised | Condyline Paint | Dose and Method of Administration, Nature and Contents of Container, Overdose |
Revised | Coregas Medical Air | Nature and Contents of Container, Pharmacological Properties, Special Precautions for Disposal |
Revised | Coregas Medical Carbon Dioxide | TGA Date |
Revised | COVID-19 Vaccine AstraZeneca | Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Cozaar | Sponsor |
Revised | Cyprone 100 | Physicochemical Properties, Special Warnings and Precautions for Use |
Revised | Cyprone 50 | Dose and Method of Administration, Physicochemical Properties, Special Warnings and Precautions for Use |
Revised | Daktarin | Pharmaceutical Form, Physicochemical Properties, Qualitative and Quantitative Composition |
Revised | Dalacin C Injection | List of Excipients, Product Name change |
Revised | DBL Acetylcysteine Injection Concentrate | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | DBL Aciclovir Intravenous Infusion | Sponsor |
Revised | DBL Amikacin Injection | Adverse Effects (Undesirable Effects), Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | DBL Aminophylline Injection | Adverse Effects (Undesirable Effects), Incompatibilities, Overdose, Special Warnings and Precautions for Use |
Revised | DBL Diazepam Injection | Adverse Effects (Undesirable Effects), Contraindications, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | DBL Docetaxel Concentrated Injection | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | DBL Heparin Sodium Injection BP Ampoule | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use |
Revised | DBL Potassium Acetate Concentrated Injection | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | DBL Sulfamethoxazole 400 mg and Trimethoprim 80 mg Concentrate Injection BP | Interactions with Other Medicines and Other Forms of Interactions, New contraindication |
Revised | Defitelio | Special Warnings and Precautions for Use |
Revised | Diprosone | Sponsor |
Revised | Diprosone OV | Sponsor |
Revised | Duac Once Daily Gel | TGA Date |
Revised | Duodopa | Special Warnings and Precautions for Use |
Revised | Eleuphrat | Sponsor, TGA Date |
Revised | Elocon Alcohol Free Cream | Sponsor |
Revised | Elocon Ointment and Lotion | Sponsor |
Revised | Elonva | Sponsor, TGA Date |
Revised | Enbrel | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Endone | TGA Date |
Revised | Epiduo Forte | Nature and Contents of Container |
Revised | Erlyand | TGA Date |
Revised | Esbriet | Special Warnings and Precautions for Use |
Revised | Esbriet Tablets | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Escitalopram Sandoz | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Overdose, Pharmaceutical Form, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Everolimus Sandoz | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Special Warnings and Precautions for Use |
Revised | Extraneal Peritoneal Dialysis Solution | Physicochemical Properties, Qualitative and Quantitative Composition |
Revised | Fampyra | Adverse Effects (Undesirable Effects) |
Revised | Fibrovein | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Flixotide Nebules | Special Precautions for Storage |
Revised | Fluorescite | Special Warnings and Precautions for Use |
Revised | Fluotex | TGA Date |
Revised | Fycompa | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Special Precautions for Storage, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Gadovist | TGA Date |
Revised | Gardasil 9 | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation |
Revised | Gazyva | Adverse Effects (Undesirable Effects) |
Revised | Gilenya | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Glimepiride APOTEX | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Glucose 50% | Qualitative and Quantitative Composition |
Revised | Gold Cross Codeine Linctus | TGA Date |
Revised | Heparin Sodium Injection | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Hospira Levetiracetam Concentrate for IV Infusion | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Humira | Adverse Effects (Undesirable Effects) |
Revised | Hydralyte | Presentation |
Revised | Iclusig | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Imoclone | TGA Date |
Revised | Incruse Ellipta | TGA Date |
Revised | Infanrix | Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions |
Revised | Irbesartan Sandoz | Adverse Effects (Undesirable Effects) |
Revised | Isobide MR | TGA Date |
Revised | Itranox | Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Juliet-35 ED | New contraindication, Special Warnings and Precautions for Use |
Revised | Kanjinti | Adverse Effects (Undesirable Effects), Pharmacological Properties |
Revised | Kanuma | Adverse Effects (Undesirable Effects) |
Revised | Kapanol | Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Keytruda | Pharmacological Properties |
Revised | Kineret | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Kyleena | Fertility, Pregnancy and Lactation |
Revised | Lamotrigine GH | TGA Date |
Revised | Lantheus Gallium (67Ga) Citrate Injection USP | Product Name change |
Revised | Lenvima | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Lipex | Adverse Effects (Undesirable Effects), Sponsor |
Revised | Lipitor | Sponsor |
Revised | Logynon ED | Pharmaceutical Form, TGA Date |
Revised | Lukair | Fertility, Pregnancy and Lactation, Sponsor |
Revised | Lynparza Capsules | Adverse Effects (Undesirable Effects) |
Revised | Lynparza Tablets | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties |
Revised | Marvelon 28 | Sponsor |
Revised | Medicianz Mupirocin Ointment | TGA Date |
Revised | Melotin MR | TGA Date |
Revised | Mezavant | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Microlut | TGA Date |
Revised | Micronelle 20 ED | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Micronelle 30 ED | Special Warnings and Precautions for Use |
Revised | Mirena | Fertility, Pregnancy and Lactation |
Revised | Morphine Juno | Boxed Warnings, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, New contraindication, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Murelax | TGA Date |
Revised | MZ Clonidine HCl Injection | TGA Date |
Revised | Nasonex Aqueous Nasal Spray 0.05% Alcohol Free | Sponsor |
Revised | Nausetil | Effects on Ability to Drive and Use Machines, Nature and Contents of Container |
Revised | Neo-Mercazole | Nature and Contents of Container |
Revised | Neulasta Syringe with Automatic Needle Guard | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Neupogen | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Neuroccord | Boxed Warnings, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Nexavar | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Nexazole | Adverse Effects (Undesirable Effects) |
Revised | Norvasc | Sponsor |
Revised | Novasone | Poisons Schedule |
Revised | Ocuflox | TGA Date |
Revised | Olumiant | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Opdivo | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Orgalutran | Sponsor |
Revised | Oxycodone BNM | Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Oxycodone Mylan | Contraindications, Nature and Contents of Container |
Revised | Panamax Co | Nature and Contents of Container |
Revised | Pariet 10 | TGA Date |
Revised | Pavtide | TGA Date |
Revised | Pfizer (Australia) Sodium Bicarbonate 8.4% Injection BP | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Pharmacor Mycophenolate 250 | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties |
Revised | Pharmacor Zolpidem | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Pheburane | Physicochemical Properties |
Revised | Phenobarbitone Injection (Aspen Pharmacare) | Sponsor |
Revised | Pregabalin Alphapharm | Boxed Warnings, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Pregabalin Sandoz | Boxed Warnings, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Prodeine Forte | Nature and Contents of Container |
Revised | Puregon | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Nature and Contents of Container, Overdosage, Special Warnings and Precautions for Use, Sponsor |
Revised | Puri-Nethol | Nature and Contents of Container |
Revised | Quinine Dihydrochloride 6% (Phebra) Sterile Concentrate | TGA Date |
Revised | Rhinocort Hayfever & Allergy Extra Strength | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Rifadin | Adverse Effects (Undesirable Effects) |
Revised | Rinvoq | Special Warnings and Precautions for Use |
Revised | Ristempa | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Scandonest 2% Special | New contraindication, Special Warnings and Precautions for Use |
Revised | Scandonest 3% | New contraindication, Special Warnings and Precautions for Use |
Revised | Sensipar | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Seretide | TGA Date |
Revised | Sertra | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, List of Excipients, Nature and Contents of Container, Overdose, Pharmaceutical Form, Pharmacological Properties, Physicochemical Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use, Sponsor, Therapeutic Indications |
Revised | Silcap | TGA Date |
Revised | Simponi | Adverse Effects (Undesirable Effects) |
Revised | Simvar | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Sinemet | Sponsor, TGA Date |
Revised | Singulair | Fertility, Pregnancy and Lactation, Sponsor |
Revised | Sodium Bicarbonate 8.4% Injection | TGA Date |
Revised | Solavert | Physicochemical Properties |
Revised | Solicare ODT | TGA Date |
Revised | Solu-Medrol | Therapeutic Indications |
Revised | Somavert | Special Precautions for Storage |
Revised | Sotacor | Special Warnings and Precautions for Use |
Revised | Spray-Tish | Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Spray-Tish Menthol | Qualitative and Quantitative Composition |
Revised | Staphylex | List of Excipients |
Revised | Stildem | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Stivarga | Adverse Effects (Undesirable Effects), Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Strensiq | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Telnasal Allergy Spray | Nature and Contents of Container |
Revised | Tenofovir EMT GH | List of Excipients |
Revised | Teveten | List of Excipients |
Revised | Tezmota | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Thioprine 50 | Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Tobra-Day | TGA Date |
Revised | Tomudex | Adverse Effects (Undesirable Effects), Contraindications, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Overdose |
Revised | Toujeo | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | Tramedo | Adverse Effects (Undesirable Effects), Boxed Warnings, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Triquilar ED | Pharmaceutical Form, TGA Date |
Revised | Uremide | TGA Date |
Revised | Ventolin Nebules | TGA Date |
Revised | Ventolin Obstetric Injection | Pharmaceutical Form, Physicochemical Properties, Special Precautions for Storage |
Revised | Viaflo 5% Glucose Intravenous Infusion | Special Precautions for Storage |
Revised | Vivotif Oral | TGA Date |
Revised | Volibris | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Votrient | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Vttack | Interactions with Other Medicines and Other Forms of Interactions, New contraindication |
Revised | Vytorin | Sponsor |
Revised | Wafesil | Dose and Method of Administration |
Revised | Xalacom | Sponsor, TGA Date |
Revised | Xalatan | Sponsor |
Revised | Zaditen | TGA Date |
Revised | Zaldiar | TGA Date |
Revised | Zavedos | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Zeklen | Sponsor |
Revised | Zeldox | Dose and Method of Administration |
Revised | Zestril | TGA Date |
Revised | Zocor | Adverse Effects (Undesirable Effects), Sponsor |
Revised | Zyloprim | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, Overdose, Pharmaceutical Form, Physicochemical Properties, Special Precautions for Storage, Special Warnings and Precautions for Use |
Deleted | Ceftazidime Aspen | |
Deleted | Ciproxin IV | |
Deleted | Panadol Cold & Flu Max Hot Lemon | |
Deleted | Panadol Cold & Flu Relief + Cough | |
Deleted | Paracea Forte | |
Deleted | Ranitidine Sandoz Injection 50 mg/5 mL | |
Deleted | Robitussin Chesty Cough & Nasal Congestion PS Oral Liquid | |
Deleted | Somatuline LA |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Suite 302, Level 3, 53 Berry Street
North Sydney NSW 2060
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au